Clinical Trial Update: G-CSF to Treat Crohn's Disease [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating granulocyte colony-stimulating factor (G-CSF) for Crohn's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• G-CSF (granulocyte colony-stimulating factor)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Crohn's Disease | Phase 1 | Status: COMPLETED